In the staging of aggressive non-Hodgkin lymphoma (NHL), bone marrow biopsy can be omitted if patients are evaluated with 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG ...

Researchers from EMBL, the University Medical Center Mainz (UMC Mainz), and the Department of Biomedicine (Basel) have ...

Bone marrow aspiration and biopsy are cornerstone diagnostic procedures within haematology and oncology, routinely employed to assess disorders ranging from haematological malignancies to metabolic ...

Researchers map how inflammatory stromal and immune cell shifts in bone marrow promote CHIP and MDS long before symptoms ...

Please provide your email address to receive an email when new articles are posted on . Accounting for the benign rs2814778-CC genotype when considering a bone marrow biopsy could avoid unnecessary ...

The change took almost 5 weeks off the time it took get a patient diagnosed and, if needed, treated, reported Kyle Stimpert, RN, MSN, ACNP, of the Department of Hematology/Oncology at VA Northeast ...

After battling leukemia last year and working to regain her strength, 50-year-old Nikki Mysliwiec is embracing a new chapter: ...

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to ...

I work as a nurse practitioner in a hematology/oncology department. Although my formal role is the coordinator for the hemophilia & thrombosis treatment center, I also coordinate the bone marrow ...

Cost effective analysis of ramucirumab and nivolumab in the second-line treatment of metastatic non-small cell lung cancer using open claim dataset. Financial toxicity in a large cohort of thyroid ...

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the ...